INS and diabetes mellitus: Metformin is known as an insulin sensitizer and has been demonstrated to prevent the development of diabetes, promote weight loss, and reduce the incidence of metabolic syndrome, which may lead to a more favorable cardiovascular risk profile [94,95,96,97,98].